AlphaSense announced that Christopher Salatto, Head of Competitive Intelligence at Pfizer, will speak on turning clinical and market signals into commercial strategy at the AlphaSummit speaker lineup.

AlphaSense is the technology behind the business world’s most important decisions – from Wall Street to boardrooms across every major industry. Trusted by over 6,500 leading companies – including 88% of the S&P 100, 80% of top global banks, and all 20 of the world’s largest pharmaceutical firms – our AI search and market intelligence platform empowers business leaders to move faster and with greater confidence by delivering the right insights at the right moment. Whether investing, acquiring, advising, or launching, AlphaSense fuels the decisions where clarity creates competitive edge. Headquartered in New York City, AlphaSense employs over 2,500 people across offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com.